"10.1371_journal.pone.0026539","plos one","2011-10-24T00:00:00Z","Azharuddin Sajid Syed Khaja; Leszek Helczynski; Anders Edsjö; Roy Ehrnström; Anna Lindgren; David Ulmert; Tommy Andersson; Anders Bjartell","Division of Urological Cancers, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden; Center for Molecular Pathology, Lund University, Skåne University Hospital, Malmö, Sweden; Division of Cell and Experimental Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden; University and Regional Laboratories Region Skåne, Clinical Pathology, Malmö, Sweden; Department of Mathematical Statistics, Center for Mathematical Sciences, Lund University, Lund, Sweden","Conceived and designed the experiments: TA AB. Performed the experiments: ASSK. Analyzed the data: ASSK LH AE RE AL TA AB. Contributed reagents/materials/analysis tools: DU AL AB TA LH. Wrote the paper: ASSK TA AB AE.","The authors have read the journal's policy and have the following conflicts: a patent application has been submitted with Anders Bjartell and Tommy Andersson as inventors in which they, based on the present results, propose to treat prostate cancer patients with tumours with a low endogenous Wnt5a expression with a substance that reconstitutes Wnt5a signaling in the prostate tumours of such patients. This application does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.","2011","10","Azharuddin Sajid Syed Khaja","ASSK",8,TRUE,2,1,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
